ArticleInternational urology and nephrology2026
Clinical characteristics and kidney outcomes in children with posterior urethral valve: a single-center experience.
Article in International urology and nephrology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
INTRODUCTION AND
aimPosterior urethral valve (PUV) represent a congenital obstructive uropathy, and despite advances in prenatal diagnosis and postnatal management, chronic kidney disease (CKD) develops in nearly 20% of affected patients. The aim of this study is to determine the clinical characteristics and kidney outcomes in children with PUV. MATERIALS AND
methodsA total of 52 boys followed with a diagnosis of posterior urethral valves were retrospectively evaluated. Data regarding antenatal diagnosis, age at admission, and timing of cystoscopic diagnosis were recorded. Clinical and laboratory data, including serum creatinine levels and glomerular filtration rate, ultrasonographic findings, urodynamic study results, DMSA findings, and voiding cystourethrography results, were collected. In addition, lower urinary tract symptoms and the frequency of lower urinary tract infections were documented.
findingsThe mean age of the 52 patients was 9.8 ± 4.8 years, and the mean age at diagnosis was 28 ± 41 months. Antenatal diagnosis was present in 32 patients (64%) and CKD developed in 10 patients (19.2%). There was no significant difference in antenatal diagnosis rates between patients with and without CKD. In the non-CKD group, hydronephrosis grades decreased significantly at the last follow-up compared with baseline, whereas no significant improvement was observed in the CKD group. These patients had more severe and persistent hydronephrosis at final evaluation. Patients with CKD had higher ratios of increased bladder wall thickness and renal echogenicity at baseline and ureteral dilatation at final follow-up. In the baseline renal function model, baseline GFR was independently associated with CKD, but proteinuria did not retain statistical significance in multivariable analysis. There was no significant difference between groups regarding severe bladder dysfunction, DMSA renal scarring, vesicoureteral reflux grades, recurrent urinary tract infections, or incontinence.
conclusionOur findings suggest that renal damage in children with PUV may begin during the antenatal period. In this cohort, postnatal factors such as bladder dysfunction, vesicoureteral reflux, and recurrent urinary tract infections were not significantly associated with CKD. Persistent hydronephrosis at last follow-up was more commonly observed in children with CKD. In multivariable analysis, baseline renal function was significantly associated with CKD development.
Indexed as
Identifiers
41995987What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.